study	group	count	intervention	measurement_type	substance	tissue	method	label	time	time_unit	mean	median	min	max	mean_sd	mean_se	cv	comments	mean_unit	median_unit
Alalawneh2024	obese	18.0	RIV20	excretion rate	rivaroxaban	urine	LC/MS	rivaroxaban_excretion_urine_obese	1.66	hr	2.5491215727060456e-10				1.6569290222589295e-10			mid-point interval	mole/second	mg/hr
Alalawneh2024	obese	18.0	RIV20	excretion rate	rivaroxaban	urine	LC/MS	rivaroxaban_excretion_urine_obese	4.72	hr	3.441314123153161e-10				1.338288825670674e-10			mid-point interval	mole/second	mg/hr
Alalawneh2024	obese	18.0	RIV20	excretion rate	rivaroxaban	urine	LC/MS	rivaroxaban_excretion_urine_obese	7.67	hr	2.8040337299766496e-10				1.338288825670674e-10			mid-point interval	mole/second	mg/hr
Alalawneh2024	obese	18.0	RIV20	excretion rate	rivaroxaban	urine	LC/MS	rivaroxaban_excretion_urine_obese	10.72	hr	1.8481131402118829e-10				6.372803931765114e-11			mid-point interval	mole/second	mg/hr
Alalawneh2024	obese	18.0	RIV20	excretion rate	rivaroxaban	urine	LC/MS	rivaroxaban_excretion_urine_obese	13.73	hr	1.0196486290824181e-10				5.034515106094439e-11			mid-point interval; incorrect value in table: 0.79 	mole/second	mg/hr
Alalawneh2024	obese	18.0	RIV20	excretion rate	rivaroxaban	urine	LC/MS	rivaroxaban_excretion_urine_obese	16.76	hr	4.46096275223558e-11				2.5491215727060452e-11			mid-point interval	mole/second	mg/hr
